Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations

Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations
复制标题

DOI:
10.1016/s0895-4356(98)00097-3
复制
发表时间:
1998-11-01
影响因子:
7.2
通讯作者:
Verrips, E
Verrips, E
中科院分区:
医学2区
文献类型:
--
作者:
Aaronson, NK;Muller, M;Verrips, E

文献摘要

被引文献

相似文献

本研究的主要目的是翻译;验证并生成关于SF-36健康调查的规范数据,供荷兰语居民使用。SF-36的荷兰语翻译遵循了由IQOLA项目开发的逐步迭代程序。经过广泛的试点测试,SF-36被用于:(1)阿姆斯特丹成年居民的随机样本(n = 4172);(2)全国成年人随机抽样(n = 1742);(3)偏头痛患者样本(423例);(4)接受积极抗肿瘤治疗的癌症患者样本(n = 485)。这四项研究的数据质量一直很高。在项目水平上,数据缺失率从1%到5%不等,在量表水平上,数据缺失率从1.2%到2.6%不等。多性状量表分析证实了SF-36的假设量表结构和相关量表得分。除了一种情况(癌症样本中的社会功能不正常)外,所有情况下,Cronbach的alpha系数都超过了0.70标准,所有尺度和样本的平均alpha系数为0.84。已知组比较结果一致支持SF-36的有效性。在两个社区样本中,SF-36平均量表得分作为年龄、性别和慢性健康状况患病率的函数观察到统计学上的显著差异。在偏头痛和癌症样本中,SF-36量表的平均得分随疾病严重程度的各种指标的变化而显著不同。两个群落样本的SF-36谱高度相似。癌症样本的SF-36得分最低,偏头痛样本处于中间位置。正在进行的研究将产生关于SF-36随时间对组内健康变化的反应性的数据。目前正在努力翻译和验证调查问卷,以供荷兰少数民族群体使用。(C) 1998爱思唯尔科学有限公司
The primary objectives of this research were to translate; validate, and generate normative data on the SF-36 Health Survey for use among Dutch-speaking residents of the Netherlands. Translation of the SF-36 into Dutch followed the stepwise, iterative procedures developed by the IQOLA Project. Following extensive pilot testing, the SF-36 was administered to: (1) a random sample of adult residents of Amsterdam (n = 4172); (2) a random, nationwide sample of adults (n = 1742); (3) a sample of migraine sufferers (n = 423); and (4) a sample of cancer patients undergoing active anti-neoplastic treatment (n = 485). Data quality across the four studies was consistently high. The rates of missing data ranged from 1% to 5% at the item level, and from 1.2% to 2.6% at the scale level. Multitrait scaling analysis confirmed the hypothesized scale structure of the SF-36 and associated scale scoring in all four samples. Cronbach's alpha coefficients surpassed the 0.70-criterion for group comparisons in all but one case (the Social Functioning stale in the cancer sample), with a mean alpha coefficient across all scales and samples of 0.84. Known-group comparisons yielded consistent support for the validity of the SF-36. In the two community samples, statistically significant differences in SF-36 mean scale scores were observed as a function of age, gender, and the prevalence of chronic health conditions. In the migraine and cancer samples, mean SF-36 scale scores varied significantly as a function of Various indicators of disease severity. The SF-36 profiles for the two community samples were highly similar. The cancer sample yielded the lowest SF-36 scores, with the migraine sample holding an intermediate position. On-going studies will generate data on the responsiveness of the SF-36 to within-group changes in health over time. Efforts are underway to translate and validate the questionnaire for use among ethnic minority groups in the Netherlands. (C) 1998 Elsevier Science Inc.